newsfilter
← Latest News
Business Wire·

Infinity Pharmaceuticals Reports Full Year 2022 Financial Results

– Infinity ended 2022 with total cash and cash equivalents of $38.3 million – – Infinity Previously Announced Definitive Merger Agreement with MEI Pharma to Advance Three Promising Clinical Oncology Candidates